The effects of keratinocyte growth factor in preclinical models of mucositis.
about
Novel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory?Oral complications in hematopoietic stem cell recipients: the role of inflammationResearch progress in the radioprotective effect of the canonical Wnt pathwayOral and intestinal mucositis - causes and possible treatments.Molecular markers of radiation-related normal tissue toxicity.Radiation-Induced Oral MucositisRandomized phase II study of palifermin for reducing dysphagia in patients receiving concurrent chemoradiotherapy for locally advanced unresectable non-small cell lung cancerR-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/beta-catenin pathway.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo.Activated hepatic stellate cells express keratinocyte growth factor in chronic liver diseaseFibroblast growth factors in epithelial repair and cytoprotection.Comprehensive Assessment of Host Responses to 5-Fluorouracil-Induced Oral Mucositis through Transcriptomic AnalysisA Dunnione Compound MB12662 Improves Cisplatin-Induced Tissue Injury and EmesisProtected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury.Chimonanthus nitens var. salicifolius Aqueous Extract Protects against 5-Fluorouracil Induced Gastrointestinal Mucositis in a Mouse ModelKeratinocyte growth factor.Effect of Transplantation of Bone Marrow Derived Mesenchymal Stem Cells and Platelets Rich Plasma on Experimental Model of Radiation Induced Oral Mucosal Injury in Albino Rats.Pharmacokinetic evaluation of palifermin for mucosal protection from chemotherapy and radiation.Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients.Fibroblast Growth Factors in the Gastrointestinal Tract: Twists and Turns.KGF promotes integrin alpha5 expression through CCAAT/enhancer-binding protein-beta.Palifermin for management of treatment-induced oral mucositis in cancer patients.Adenovirus-mediated expression of keratinocyte growth factor promotes secondary flap necrotic wound healing in an extended animal model.Novel agents in the treatment of intestinal failure: humoral factors.Cell kinetic studies in the murine ventral tongue epithelium: the effects of repeated exposure to keratinocyte growth factor.Efficacy of palifermin on oral mucositis and acute GVHD after hematopoietic stem cell transplantation (HSCT) in hematology malignancy patients: a meta-analysis of trials.Effects of epidermal growth factor and keratinocyte growth factor on the growth of oropharyngeal keratinocytes in coculture with autologous fibroblasts in a three-dimensional matrix.Keratinocyte growth factor pretreatment prevents radiation-induced intestinal damage in a mouse model.
P2860
Q26823881-11EFD2F9-397A-46BD-8EE8-4BAC1943ACD6Q27027650-48699F07-CE25-4061-89D7-21200A72669CQ28386021-FFB395EA-CED5-4E17-9B26-242E850BE5DBQ33195001-90CDE49D-6D33-46D6-8161-D5186FD97D57Q33568202-22181C9A-1B1E-494C-A3CE-DDBB92B29FC0Q33711362-F3D028E7-7841-4154-A648-35FCB1F944B8Q34836491-60AEAC17-01E0-4C70-B45F-D560772672EDQ34932642-CDC92E21-23B2-4B1F-B354-81FE89FED13DQ35022269-DD6C0449-7340-4D66-AC51-4B3AB2EC37A0Q35094462-3AFCCBD1-373B-4D3A-8CB6-033C3D5D4B1DQ35103291-42DDE44F-B8A3-4D9B-ACE6-3C76ECC9A17FQ35213955-DE414DE0-D212-438C-B0C6-6ACB198ED99DQ35743724-1721D922-ACAA-427E-8183-41C5580E3C66Q36015715-421BF90A-07D8-462E-8AE7-EFF754A76272Q36282619-D3EF9C54-9656-445C-8D09-F68B1F7D32DDQ37400586-1D7634B6-0473-4626-A5E0-9CCBF7C29518Q37489900-8B3C2D5D-9A51-40A1-9D2A-5A680DCE5999Q37694235-FB7A0EF5-D25F-4E32-B40B-C59D5E657589Q37854688-457A214E-08A2-4AD5-88F5-0103091ACB8FQ38044278-B63B1B07-92CD-4A86-B9ED-0B2195F6FC94Q39136136-683834BE-B5B2-42E8-A69F-80AADCC8E714Q40114582-08DA06C8-2F21-4CE6-97BD-D1A46F02099AQ42052507-260A7B19-2449-42FF-ABCB-21C0B90E3B3AQ42276479-D2F4A4AF-8CA9-4414-8CE2-6EDC0489AE45Q42410575-E3EDAB12-EE9A-41F5-A58D-3656E50234E8Q42524124-B7078E41-0FF5-4F2C-BA95-62F1EEBE4741Q49332936-0CF8639A-5E71-46AD-AF8C-ADED3500132DQ51172158-545343B4-1096-4E13-9BED-F98C2F7A369DQ52638842-D1DA011B-EA00-4F60-9C82-16FA6572D04A
P2860
The effects of keratinocyte growth factor in preclinical models of mucositis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
The effects of keratinocyte growth factor in preclinical models of mucositis.
@ast
The effects of keratinocyte growth factor in preclinical models of mucositis.
@en
The effects of keratinocyte growth factor in preclinical models of mucositis.
@nl
type
label
The effects of keratinocyte growth factor in preclinical models of mucositis.
@ast
The effects of keratinocyte growth factor in preclinical models of mucositis.
@en
The effects of keratinocyte growth factor in preclinical models of mucositis.
@nl
prefLabel
The effects of keratinocyte growth factor in preclinical models of mucositis.
@ast
The effects of keratinocyte growth factor in preclinical models of mucositis.
@en
The effects of keratinocyte growth factor in preclinical models of mucositis.
@nl
P2093
P2860
P1433
P1476
The effects of keratinocyte growth factor in preclinical models of mucositis.
@en
P2093
C L Farrell
C R DiPalma
J V Bready
S A Kaufman
P2860
P356
10.1046/J.1365-2184.35.S1.8.X
P478
35 Suppl 1
P577
2002-08-01T00:00:00Z